Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis
Background—Patients who receive implantable cardioverter defibrillator therapies are at
higher risk of death versus those who do not. Programmed settings to reduce nonessential …
higher risk of death versus those who do not. Programmed settings to reduce nonessential …
Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate …
Background—The benefit of novel implantable cardioverter defibrillator (ICD) programming
in reducing inappropriate ICD therapy and mortality was demonstrated in Multicenter …
in reducing inappropriate ICD therapy and mortality was demonstrated in Multicenter …
Optimal programming of implantable cardiac-defibrillators
M Madhavan, PA Friedman - Circulation, 2013 - Am Heart Assoc
Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death risk and improve
survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary …
survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary …
[HTML][HTML] Reduction in inappropriate therapy and mortality through ICD programming
AJ Moss, C Schuger, CA Beck, MW Brown… - … England Journal of …, 2012 - Mass Medical Soc
Background The implantable cardioverter–defibrillator (ICD) is highly effective in reducing
mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are …
mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are …
The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome
I Goldenberg, DT Huang, JC Nielsen - European heart journal, 2020 - academic.oup.com
Multiple randomized multicentre clinical trials have established the role of the implantable
cardioverter-defibrillator (ICD) as the mainstay in the treatment of ventricular …
cardioverter-defibrillator (ICD) as the mainstay in the treatment of ventricular …
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure …
M Gasparini, C Menozzi, A Proclemer… - European heart …, 2009 - academic.oup.com
Aims To investigate the efficacy and safety of a cardiac resynchronization therapy with
cardioverter–defibrillator (CRT-D) device with simplified ventricular tachycardia …
cardioverter–defibrillator (CRT-D) device with simplified ventricular tachycardia …
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: a pooled analysis of 4 randomized controlled …
DJ Friedman, SM Al-Khatib, EP Zeitler, JY Han… - American heart …, 2017 - Elsevier
Background Primary prevention implantable cardioverter defibrillator (ICD) reduce all-cause
mortality by reducing sudden cardiac death. There are conflicting data regarding whether …
mortality by reducing sudden cardiac death. There are conflicting data regarding whether …
Implantable cardioverter-defibrillators for primary prevention in patients with ischemic or nonischemic cardiomyopathy: a systematic review and meta-analysis
M Kołodziejczak, F Andreotti, M Kowalewski… - Annals of internal …, 2017 - acpjournals.org
Background: Implantable cardioverter-defibrillators (ICDs) have a role in preventing cardiac
arrest in patients at risk for life-threatening ventricular arrhythmias. Purpose: To compare …
arrest in patients at risk for life-threatening ventricular arrhythmias. Purpose: To compare …
[HTML][HTML] 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and …
MK Stiles, L Fauchier, CA Morillo, BL Wilkoff - Heart Rhythm, 2020 - Elsevier
Abstract The 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal
Implantable Cardioverter-Defibrillator Programming and Testing provided guidance on …
Implantable Cardioverter-Defibrillator Programming and Testing provided guidance on …
Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials
BA Steinberg, SM Al-Khatib, R Edwards, JY Han… - JACC: Heart Failure, 2014 - jacc.org
Objectives: The aim of this study was to determine if the benefit of implantable cardioverter-
defibrillators (ICDs) is modulated by medical comorbidity. Background: Primary prevention …
defibrillators (ICDs) is modulated by medical comorbidity. Background: Primary prevention …